Werkgroep Cardiologische centra Nederland English

PROGRESS (Klaar)

A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Reduced Ejection Fraction

Middel
elamipretide
Populatie
hartfalen
Fase
II
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. D.J.A. Lok (Cardioloog)
Deventer, Deventer Ziekenhuis